Cosmos Health Stock Analysis
| COSM Stock | USD 0.47 0.01 2.17% |
IPO Date 11th of October 2012 | 200 Day MA 0.6387 | 50 Day MA 0.5775 | Beta 4.466 |
Cosmos Health has over 11.82 Million in debt which may indicate that it relies heavily on debt financing. At this time, Cosmos Health's Debt To Equity is very stable compared to the past year. As of the 5th of February 2026, Total Debt To Capitalization is likely to grow to 0.31, while Net Debt is likely to drop about 8.4 M. Cosmos Health's financial risk is the risk to Cosmos Health stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Cosmos Health's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Cosmos Health's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Cosmos Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Cosmos Health's stakeholders.
For many companies, including Cosmos Health, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Cosmos Health, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Cosmos Health's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 0.7464 | Enterprise Value Ebitda (1.60) | Price Sales 0.2923 | Shares Float 25.4 M | Wall Street Target Price 4.5 |
Cosmos Health is undervalued with Real Value of 1.47 and Target Price of 4.5. The main objective of Cosmos Health stock analysis is to determine its intrinsic value, which is an estimate of what Cosmos Health is worth, separate from its market price. There are two main types of Cosmos Health's stock analysis: fundamental analysis and technical analysis.
The Cosmos Health stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Cosmos Health is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Cosmos Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Cosmos Stock Analysis Notes
About 27.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.75. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cosmos Health recorded a loss per share of 0.77. The entity last dividend was issued on the 21st of November 2017. The firm had 1:10 split on the 21st of November 2017. Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. Cosmos Holdings Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois. Cosmos Holdings operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 95 people. For more info on Cosmos Health please contact Grigorios Siokas at 312 536 3102 or go to https://www.cosmoshealthinc.com.Cosmos Health Investment Alerts
| Cosmos Health generated a negative expected return over the last 90 days | |
| Cosmos Health has high historical volatility and very poor performance | |
| Cosmos Health has some characteristics of a very speculative penny stock | |
| Cosmos Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 54.43 M. Net Loss for the year was (16.18 M) with profit before overhead, payroll, taxes, and interest of 6.82 M. | |
| Cosmos Health currently holds about 322.37 K in cash with (7.72 M) of positive cash flow from operations. | |
| Cosmos Health has a poor financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Disposition of 220000 shares by Grigorios Siokas of Cosmos Health at 0.12 subject to Rule 16b-3 |
Cosmos Largest EPS Surprises
Earnings surprises can significantly impact Cosmos Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-04-12 | 2024-03-31 | -0.14 | -0.11 | 0.03 | 21 | ||
2025-08-18 | 2025-06-30 | 0.01 | -0.1 | -0.11 | 1100 | ||
2025-04-15 | 2025-03-31 | -0.08 | -0.41 | -0.33 | 412 |
Cosmos Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Group One Trading, Lp | 2025-06-30 | 4.3 K | Tower Research Capital Llc | 2025-06-30 | 3.7 K | Advisor Group Holdings, Inc. | 2025-06-30 | 2.8 K | Citigroup Inc | 2025-06-30 | 2.7 K | Bank Of America Corp | 2025-06-30 | 205 | Simplex Trading, Llc | 2025-06-30 | 180 | Sbi Securities Co Ltd | 2025-06-30 | 112 | Susquehanna International Group, Llp | 2025-03-31 | 0.0 | Foundations Investment Advisors, Llc | 2025-06-30 | 0.0 | Blackrock Inc | 2025-06-30 | 267.8 K | Geode Capital Management, Llc | 2025-06-30 | 191.6 K |
Cosmos Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.65 M.Cosmos Profitablity
The company has Profit Margin (PM) of (0.31) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.11) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.11.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.31) | (0.33) | |
| Return On Capital Employed | (0.63) | (0.59) | |
| Return On Assets | (0.27) | (0.28) | |
| Return On Equity | (0.76) | (0.72) |
Management Efficiency
Cosmos Health has return on total asset (ROA) of (0.1303) % which means that it has lost $0.1303 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6382) %, meaning that it created substantial loss on money invested by shareholders. Cosmos Health's management efficiency ratios could be used to measure how well Cosmos Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 5th of February 2026, Return On Tangible Assets is likely to drop to -0.33. In addition to that, Return On Capital Employed is likely to grow to -0.59. At this time, Cosmos Health's Total Assets are very stable compared to the past year. As of the 5th of February 2026, Net Tangible Assets is likely to grow to about 3.7 M, though Other Assets are likely to grow to (1.09).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.15 | 1.21 | |
| Tangible Book Value Per Share | 0.79 | 0.83 | |
| Enterprise Value Over EBITDA | (2.01) | (2.11) | |
| Price Book Value Ratio | 0.47 | 0.49 | |
| Enterprise Value Multiple | (2.01) | (2.11) | |
| Price Fair Value | 0.47 | 0.49 | |
| Enterprise Value | 21.9 M | 23 M |
Leadership at Cosmos Health emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Technical Drivers
As of the 5th of February, Cosmos Health shows the Risk Adjusted Performance of (0.09), mean deviation of 4.14, and Standard Deviation of 5.9. Cosmos Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cosmos Health market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Cosmos Health is priced correctly, providing market reflects its regular price of 0.47 per share. As Cosmos Health is a penny stock we also strongly suggest to validate its jensen alpha numbers.Cosmos Health Price Movement Analysis
The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Moving Average is predictive technique used to analyze Cosmos Health price data points by creating a series of averages of different subsets of Cosmos Health entire price series.
Cosmos Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cosmos Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cosmos Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cosmos Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cosmos Health Outstanding Bonds
Cosmos Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cosmos Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cosmos bonds can be classified according to their maturity, which is the date when Cosmos Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Cosmos Health Predictive Daily Indicators
Cosmos Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cosmos Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 93054.7 | |||
| Daily Balance Of Power | 0.2 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 0.48 | |||
| Day Typical Price | 0.47 | |||
| Period Momentum Indicator | 0.01 |
Cosmos Health Forecast Models
Cosmos Health's time-series forecasting models are one of many Cosmos Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cosmos Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Cosmos Health Bond Ratings
Cosmos Health financial ratings play a critical role in determining how much Cosmos Health have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Cosmos Health's borrowing costs.| Piotroski F Score | 4 | Poor | View |
| Beneish M Score | (2.93) | Unlikely Manipulator | View |
Cosmos Health Debt to Cash Allocation
Many companies such as Cosmos Health, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Cosmos Health currently holds 11.82 M in liabilities with Debt to Equity (D/E) ratio of 4.79, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Cosmos Health has a current ratio of 1.03, suggesting that it is in a questionable position to pay out its financial obligations when due. Note, when we think about Cosmos Health's use of debt, we should always consider it together with its cash and equity.Cosmos Health Total Current Liabilities Over Time
Cosmos Health Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Cosmos Health uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Cosmos Health Debt Ratio | 24.0 |
Cosmos Health Corporate Bonds Issued
Cosmos Short Long Term Debt Total
Short Long Term Debt Total |
|
About Cosmos Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Cosmos Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cosmos shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cosmos Health. By using and applying Cosmos Stock analysis, traders can create a robust methodology for identifying Cosmos entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.27) | (0.28) | |
| Operating Profit Margin | (0.33) | (0.31) | |
| Net Loss | (0.27) | (0.28) | |
| Gross Profit Margin | 0.09 | 0.09 |
Current Cosmos Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cosmos analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cosmos analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 4.5 | Buy | 1 | Odds |
Most Cosmos analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cosmos stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cosmos Health, talking to its executives and customers, or listening to Cosmos conference calls.
Cosmos Stock Analysis Indicators
Cosmos Health stock analysis indicators help investors evaluate how Cosmos Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cosmos Health shares will generate the highest return on investment. By understating and applying Cosmos Health stock analysis, traders can identify Cosmos Health position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 3.8 M | |
| Long Term Debt | 1.6 M | |
| Common Stock Shares Outstanding | 19.1 M | |
| Total Stockholder Equity | 24.5 M | |
| Total Cashflows From Investing Activities | -798.3 K | |
| Property Plant And Equipment Net | 10.4 M | |
| Cash And Short Term Investments | 336.3 K | |
| Cash | 315.1 K | |
| Accounts Payable | 11.2 M | |
| Net Debt | 11.5 M | |
| 50 Day M A | 0.5775 | |
| Total Current Liabilities | 25.8 M | |
| Other Operating Expenses | 70 M | |
| Non Current Assets Total | 28.9 M | |
| Forward Price Earnings | 52.6316 | |
| Non Currrent Assets Other | 4.9 M | |
| Stock Based Compensation | 1.7 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Will Health Care Providers & Services sector continue expanding? Could Cosmos diversify its offerings? Factors like these will boost the valuation of Cosmos Health. Projected growth potential of Cosmos fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cosmos Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.379 | Return On Assets | Return On Equity |
Investors evaluate Cosmos Health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cosmos Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cosmos Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between Cosmos Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cosmos Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cosmos Health's market price signifies the transaction level at which participants voluntarily complete trades.